Sponsor: Qiagen REGISTER NOW Broadcast Date: September 12, 2019 Time: 8:00 am PT, 11:00 am ET, 17:00 CET BRCA1/BRCA2 genes represent the best examples for our current understanding of...
Sponsor: Molecular MDCodevelopment is an intermittent and uncertain process. Adopting an agnostic approach to the challenges associated with platform and method selection provide added degrees of freedom for strategic development and selection of the most appropriate clinical trial assay.
Sponsor: QIAGENThis groundbreaking webinar will discuss how NGS technologies have aided clinicians in the diagnosis and treatment of hematologic cancer.
Sponsor: Clinical OMICsThis webinar focuses on scientific, clinical, and patient-oriented strategies to help WGS's high clinical expectations.
Sponsor: TakedaTakeda has taken great strides in incorporating a patient-centric approach to drug development through the use of minimally invasive and less frequent testing procedures while maintaining the power and rigor of the clinical trial.
Sponsored content brought to you by What if every patient’s oncologist or lab testing personnel had access to an online digital encyclopedia of cancer mutations,...
Sponsor: RocheNew equipment and methodologies have allowed researchers to streamline their IHC and ISH workflows.
Sponsor: ThermoFisher ScientificIn this webinar, multiplexing quantitative proteomics for profiling breast cancer patient-derived xenografts will be discussed.
Sponsor: Bio-RadIn this webinar we will hear how GenQA addresses some of the challenges in providing quality assessments for ctDNA testing.
Sponsor: ThermoFisher Scientific VIEW NOW Broadcast Date: June 26, 2019 Time: 8:00 am PT, 11:00 am ET, 17:00 CET Protein structure must be studied in its native cellular environment, otherwise,...